Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 10/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1649659 | 0.88 | FASN (0.63) | FASN | |
| SCHEMBL1785484 | 0.88 | FASN (0.60) | FASN | |
| SCHEMBL4742082 | 0.85 | FASN (0.63) | FASN | |
| SCHEMBL30212063 | 0.85 | FASN (0.70) | FASN | |
| SCHEMBL30212056 | 0.85 | FASN (0.70) | FASN | |
| SCHEMBL8904640 | 0.83 | FASN (0.38) | FASN | |
| SCHEMBL16352047 | 0.81 | FASN (0.59) | FASN | |
| SCHEMBL30212078 | 0.80 | FASN (0.63) | FASN | |
| Desaspidin SCHEMBL29613713 | 0.80 | FASN (0.51) | FASN | |
| SCHEMBL19236519 | 0.78 | FASN (0.67) | FASN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 446 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12178790-B2 | Antibacterial compound isolated from Psiloxylon mauritianum and its derivatives | SORRES, Jonathan (FR) | 2024-12-31 | — | — | US | claimed |
| CN-115804764-B | Application of secoisolariciresinol diglucoside compound in preparation of medicine with respiratory syncytial virus resisting effect | 暨南大学附属第一医院（广州华侨医院） | 2024-01-26 | — | — | CN | claimed |
| CN-116270567-A | Pharmaceutical preparation for treating diabetes | 山东中医药大学附属医院 | 2023-06-23 | — | — | CN | claimed |
| CN-115804764-A | Application of aspidin type phloroglucinol compound in preparation of medicine with respiratory syncytial virus resisting effect | 暨南大学附属第一医院（广州华侨医院） | 2023-03-17 | — | — | CN | claimed |
| US-20230062900-A1 | NEW ANTIBACTERIAL COMPOUND ISOLATED FROM PSILOXYLON MAURITIANUM AND ITS DERIVATIVES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2023-03-02 | — | — | US | claimed |
| CN-110742877-B | Medical application of aspidin ABBA in preparation of anti-pneumolysin | 吉林大学 | 2022-06-07 | — | — | CN | claimed |
| CN-109908120-B | Effective component of Dryopteris stenoptera, extraction method and application thereof | 井冈山大学 | 2022-04-19 | — | — | CN | claimed |
| CN-110742877-A | Medical application of aspidin ABBA in preparation of anti-pneumolysin | 吉林大学 | 2020-02-04 | — | — | CN | claimed |
| CN-103102255-A | Method for separating and purifying four phloroglucinol compounds from dryopteris fragrans | UNIV NORTHEAST FORESTRY | 2013-05-15 | — | — | CN | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-5807898-A | ASPIDIN, DESASPIDIN, METHYLENEBISASPIDINOL | KAPADIA GOVIND J (US) | 1998-09-15 | — | — | US | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| CN-119769635-A | Chinese herbal medicine feed additive for fattening sheep and preparation method thereof | 徐州生物工程职业技术学院 | 2025-04-08 | — | — | CN | disclosed |
| US-12178790-B2 | Antibacterial compound isolated from Psiloxylon mauritianum and its derivatives | SORRES, Jonathan (FR) | 2024-12-31 | — | — | US | disclosed |
| US-4737491-A | COPPER OR ZINC COMPLEXES | KEMIRA OY (FI) | 1988-04-12 | — | — | US | disclosed |
| US-4530829-A | Mixture of tannic acid and ethylenediaminetetraacetic acid | KAO CORPORATION (JP) | 1985-07-23 | — | — | US | disclosed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230062900-A1 | NEW ANTIBACTERIAL COMPOUND ISOLATED FROM PSILOXYLON MAURITIANUM AND ITS DERIVATIVES | PNN, AAAS, MRPS35 | FASN 37/4885 |
| US-12178790-B2 | Antibacterial compound isolated from Psiloxylon mauritianum and its derivatives | AAAS, PNN, MRPL9 | FASN 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.